Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Flex Pharma Seals Financing

by Lisa M. Jarvis
September 15, 2014 | A version of this story appeared in Volume 92, Issue 37

Boston-based Flex Pharma has secured $40 million in financing from a wide range of public and private investors. The months-old biotech firm is focused on developing drugs to treat muscle cramps and spasms using technology developed by its scientific cofounder, Roderick MacKinnon, who won the 2003 Nobel Prize in Chemistry for his work on ion channels. Flex Pharma is led by Christoph Westphal, who previously started Sirtris, a biotech firm sold to GlaxoSmithKline in 2008 for $720 million; last year GSK shut the unit down.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.